Filled with the top stories to start your day, and emergency news alerts.

GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID ...

Trade Fight Widens as Europe and Canada Retaliate Against Trump Tariffs As President Trump’s global tariffs on metals took effect, the European Union and Canada announced billions of dollars in ...